Tell Us, If Fits Subside Quickly, Does Anavex Work?
Please, render for us your cogent explanation should the following occur.
If in the upcoming Rett trial of little girls with this neurological condition, fraught with, among other symptoms, frequent epileptic fits and poor muscle control, Anavex 2-73 is administered blindly, in orange juice, apple sauce, or otherwise in a form the little girls cannot detect, and in say, in just three weeks of this, their mothers note that their frequent episodes of epileptic fits and poor muscle control markedly abate, would this be any indication the drug has authentic efficacy?
How should we unknowing AVXL shareholders react to some mother who might post here, "Hey, my little Susie has Rett, and after a month in that Anavex study no she longer has fits, and she's starting to walk normally!"
Without a proper two-armed study, real-drug and placebo, how could the upcoming Rett trial yield any scientifically valid results?
And, it's only for three months. Is that long enough to test a drug acting on a from-birth genetic anomaly?
Like yourself, we should be wary, should we not? Guide us. How should we interpret any interim results in any of the upcoming Anavex 2-73 clinical trials. We all messed up with the Australian study. We need guidance more so now. Most of us bought some AVXLs. Pretty risky, that was.
Market Data 
Markets 
AI
